profound aminos tirzepatide Home TIRZEPATIDE – Research Peptide |

Oxidized tirzepatide may still bind to its target receptors, but with reduced affinity

A 2022 clinical trial funded by Novo Nordisk (which makes Ozempic and Wegovy) found that a weekly dose of one GLP-1 drug reduced heavy-drinking days and total intake for people struggling with alcohol use disorder but only in a subgroup of patients with a BMI over 30

There's a question I haven't been able to answer in my research: by how much exactly do these drugs increase GLP-1, and specifically how much more do they activate GLP-1 receptors

Confusingly, Ozempic has become the byword for the once-weekly shot regardless of which version of the drug they are taking